a:5:{s:8:"template";s:9184:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8"/>
<meta content="text/html; charset=utf-8" http-equiv="content-type"/>
<meta content="IE=edge" http-equiv="X-UA-Compatible"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<title>{{ keyword }}</title>
<link href="https://fonts.googleapis.com/css?family=Roboto+Condensed%3A300%2C300i%2C400%2C400i%2C600%2C600i%2C800%2C800i&amp;subset=latin%2Clatin-ext" id="bulk-fonts-css" media="all" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css">@supports ((position:-webkit-sticky) or (position:sticky)){}@supports ((position:-webkit-sticky) or (position:sticky)){}@supports ((position:-webkit-sticky) or (position:sticky)){}p.has-drop-cap:not(:focus)::first-letter{float:left;font-size:8.4em;line-height:.68;font-weight:100;margin:.05em .1em 0 0;text-transform:uppercase;font-style:normal}p.has-drop-cap:not(:focus)::after{content:"";display:table;clear:both;padding-top:14px} @font-face{font-family:'Roboto Condensed';font-style:italic;font-weight:300;src:local('Roboto Condensed Light Italic'),local('RobotoCondensed-LightItalic'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVg2ZhZI2eCN5jzbjEETS9weq8-19eDpCEoY9Nc.ttf) format('truetype')}@font-face{font-family:'Roboto Condensed';font-style:italic;font-weight:400;src:local('Roboto Condensed Italic'),local('RobotoCondensed-Italic'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVj2ZhZI2eCN5jzbjEETS9weq8-19eLAQM4.ttf) format('truetype')}@font-face{font-family:'Roboto Condensed';font-style:normal;font-weight:300;src:local('Roboto Condensed Light'),local('RobotoCondensed-Light'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVi2ZhZI2eCN5jzbjEETS9weq8-33mZGCoYag.ttf) format('truetype')}@font-face{font-family:'Roboto Condensed';font-style:normal;font-weight:400;src:local('Roboto Condensed'),local('RobotoCondensed-Regular'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVl2ZhZI2eCN5jzbjEETS9weq8-19y7CA.ttf) format('truetype')} /*! normalize.css v3.0.3 | MIT License | github.com/necolas/normalize.css */html{font-family:sans-serif;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0}footer,nav{display:block}a{background-color:transparent}a:active,a:hover{outline:0}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:10px;-webkit-tap-highlight-color:transparent}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#333;background-color:#fff}a{color:#337ab7;text-decoration:none}a:focus,a:hover{color:#23527c;text-decoration:underline}a:focus{outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}p{margin:0 0 10px}.text-center{text-align:center}ul{margin-top:0;margin-bottom:10px}.container{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}.row{margin-left:-15px;margin-right:-15px}.dropdown{position:relative}.dropdown-toggle:focus{outline:0}.nav{margin-bottom:0;padding-left:0;list-style:none}.nav>li{position:relative;display:block}.nav>li>a{position:relative;display:block;padding:10px 15px}.nav>li>a:focus,.nav>li>a:hover{text-decoration:none;background-color:#eee}.navbar{position:relative;min-height:50px;margin-bottom:20px;border:1px solid transparent}@media (min-width:768px){.navbar{border-radius:4px}}@media (min-width:768px){.navbar-header{float:left}}.container>.navbar-header{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.container>.navbar-header{margin-right:0;margin-left:0}}.navbar-fixed-top{position:fixed;right:0;left:0;z-index:1030}@media (min-width:768px){.navbar-fixed-top{border-radius:0}}.navbar-fixed-top{top:0;border-width:0 0 1px}.navbar-brand{float:left;padding:15px 15px;font-size:18px;line-height:20px;height:50px}.navbar-brand:focus,.navbar-brand:hover{text-decoration:none}@media (min-width:768px){.navbar>.container .navbar-brand{margin-left:-15px}}.navbar-nav{margin:7.5px -15px}.navbar-nav>li>a{padding-top:10px;padding-bottom:10px;line-height:20px}@media (min-width:768px){.navbar-nav{float:left;margin:0}.navbar-nav>li{float:left}.navbar-nav>li>a{padding-top:15px;padding-bottom:15px}}@media (min-width:768px){.navbar-right{float:right!important;margin-right:-15px}}.navbar-default{background-color:#f8f8f8;border-color:#e7e7e7}.navbar-default .navbar-brand{color:#777}.navbar-default .navbar-brand:focus,.navbar-default .navbar-brand:hover{color:#5e5e5e;background-color:transparent}.navbar-default .navbar-nav>li>a{color:#777}.navbar-default .navbar-nav>li>a:focus,.navbar-default .navbar-nav>li>a:hover{color:#333;background-color:transparent}.container-fluid:after,.container-fluid:before,.container:after,.container:before,.nav:after,.nav:before,.navbar-header:after,.navbar-header:before,.navbar:after,.navbar:before,.row:after,.row:before{content:" ";display:table}.container-fluid:after,.container:after,.nav:after,.navbar-header:after,.navbar:after,.row:after{clear:both}@-ms-viewport{width:device-width}body,html{overflow-x:hidden}body{font-family:'Roboto Condensed',"Helvetica Neue",helvetica,arial,sans-serif;padding:0;color:#404040;font-weight:400;line-height:1.8;font-size:16px;word-wrap:break-word;overflow-x:hidden}a,a:active,a:focus,a:hover{text-decoration:none;color:#0090ff}ul{padding-left:20px}a:active{border-bottom:none}.page-area{padding-top:70px}@media (min-width:768px){.navbar-nav>li>a{padding-top:25px;padding-bottom:25px;transition:all .5s ease-in-out;-moz-transition:all .5s ease-in-out;-webkit-transition:all .5s ease-in-out;-o-transition:all .5s ease-in-out}#site-navigation .container{padding-left:0;padding-right:0}}@media (max-width:767px){.navbar-nav a:focus,.navbar-nav a:hover{color:#fff!important;background-color:#000!important}.menu-container{width:70%;position:absolute;left:0;height:100vh;transform:translate3d(-100%,0,0);overflow-y:auto;overflow-x:auto;background-color:#fff;top:100%}.navbar-brand{padding-right:55px!important}.page-area{left:0;transform:translate3d(0,0,0);transition:transform .5s ease}.navbar-nav{padding:0;margin:0}.navbar-nav a{font-size:14px;padding:12px 10px!important;margin:0!important;line-height:16px!important;float:left!important;margin:0!important;width:100%;text-transform:none!important;word-wrap:break-word;white-space:normal!important}.navbar-nav li{padding:0!important;margin:0!important}}#site-navigation{min-height:70px}.navbar-nav>li>a{border-bottom:0;text-transform:uppercase}.site-title{margin:0;padding:0;font-size:22px;line-height:28px}p.site-description{font-size:13px;line-height:18px;margin:0;-webkit-transition:all .5s ease;transition:all .5s ease}.site-branding-logo{float:left}.site-branding-logo a{border:none;z-index:9999;position:relative}.navbar-brand{padding:10px 15px;height:auto;z-index:99999;position:relative;z-index:1}.navbar{margin-bottom:0}.main-menu{position:relative}.navbar-fixed-top{position:absolute}#site-navigation{background-color:#fff;-webkit-box-shadow:0 10px 20px -12px rgba(0,0,0,.42),0 3px 20px 0 rgba(0,0,0,.12),0 8px 10px -5px rgba(0,0,0,.2);box-shadow:0 10px 20px -12px rgba(0,0,0,.42),0 3px 20px 0 rgba(0,0,0,.12),0 8px 10px -5px rgba(0,0,0,.2);border:none}#site-navigation,nav a{-webkit-transition:all .3s ease;transition:all .3s ease;color:#000}.footer-credits{border-top:1px solid #ccc;padding:15px;clear:both;margin-top:20px;background-color:#fff}</style>
 </head>
<body class="wp-custom-logo" id="blog">
<div class="main-menu">
<nav class="navbar navbar-default navbar-fixed-top" id="site-navigation">
<div class="container">
<div class="navbar-header">
<div class="site-header">
<div class="site-branding-logo">
<a class="custom-logo-link" href="#" itemprop="url" rel="home"></a> </div>
<div class="site-branding-text navbar-brand">
<p class="site-title"><a href="#" rel="home">{{ keyword }}</a></p>
<p class="site-description">
{{ keyword }}</p>
</div>
</div>
</div>
<div class="menu-container"><ul class="nav navbar-nav navbar-right" id="menu-menu-1"><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-72 dropdown" id="menu-item-72"><a class="dropdown-toggle" data-toggle="dropdown" href="#" title="Projects">Projects</a>
</li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-73 dropdown" id="menu-item-73"><a class="dropdown-toggle" data-toggle="dropdown" href="#" title="About">About</a>
</li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-74" id="menu-item-74"><a href="#" title="Contacts">Contacts</a></li>
</ul></div> </div>
</nav>
</div>
<div class="page-area">	
{{ text }}
<br>
<br>
{{ links }}
</div>
<footer class="footer-credits container-fluid row" id="colophon">
<div class="container">
<p class="footer-credits-text text-center">{{ keyword }} 2020</p>
</div>
</footer>
</body>
</html>";s:4:"text";s:10250:"® 2020 Platinum Equity Advisors, LLC. The company develops, markets, and sells blood glucose monitoring systems for home and hospital use under the global brand OneTouch. Drive share and incremental value from digital data through continued investment in technologies and software. LifeScan offers blood glucose monitoring products such as personal blood glucose meters, testing strips, lancets, point-of-care testing devices and integrated digital solutions under the OneTouch brand. Platinum Equity Submits Binding Offer to Acquire LifeScan from Johnson & Johnson. Morgan Lewis is serving as legal advisor to Platinum Equity on the acquisition of LifeScan. “We have great respect for Johnson & Johnson and appreciate their confidence in our ability to execute,” said Platinum Equity Chairman and CEO Tom Gores. Platinum Equity’s offer was made in March this year, however, Johnson & Johnson was required to consult with its work councils and the trade unions before it could formally announce the aquisition.     
     
 There was a problem submitting your request.     
         E-mail Dan. Signing up for our Newsletter is subject to our Privacy Notice. Johnson & Johnson (J&J) has completed the sale of its subsidiary LifeScan to private investment firm Platinum Equity for a total consideration of around $2.1bn. By submitting your contact information, you acknowledge that you have read our Privacy Notice and that you consent to our processing of data in accordance with our Privacy Notice. '&l=' + l : ''; j.async = true; j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f); })(window, document, 'script', 'dataLayer', 'GTM-TQKGM74'); “LifeScan is an innovative company that has been a leader in diabetes care for more than 30 years,” said Platinum Equity Partner Jacob Kotzubei. 
     
 LifeScan President Valerie Asbury would continue leading the business following the change in ownership.         function OptanonWrapper() { }
     
             (function (w, d, s, l, i) { w[l] = w[l] || []; w[l].push({ 'gtm.start': new Date().getTime(), event: 'gtm.js' }); var f = d.getElementsByTagName(s)[0], j = d.createElement(s), dl = l != 'dataLayer' ? You may unsubscribe at any time.     
 There was a problem submitting your request. By clicking 'Send' you agree to receive communications from us. LifeScan is a leader in blood glucose monitoring products with 2017 net revenue of approximately $1.5 billion. “Once our offer is accepted we will work with the management team to ensure a seamless transition on behalf of patients, healthcare providers and the company’s employees around the world,” added Mr. Kotzubei. We are an acquirer that … Principal
 +1 310.228.9514
 Partner
 LOS ANGELES (March 16, 2018) – Platinum Equity announced today that it has submitted a binding offer to acquire LifeScan, Inc. from Johnson & Johnson (NYSE: JNJ) in a transaction valued at approximately $2.1 billion. “This is an important investment for us in a business that serves millions of patients around the world. +1 310.282.9202
 Principal
     
         function OptanonWrapper() { }
     
 Our Newsletter is subject to our Privacy Notice.         function OptanonWrapper() { }
 Headquartered in Chesterbrook, Pennsylvania and Zug, Switzerland, LifeScan serves approximately 20 million patients globally in more than 90 countries.             (function (w, d, s, l, i) { w[l] = w[l] || []; w[l].push({ 'gtm.start': new Date().getTime(), event: 'gtm.js' }); var f = d.getElementsByTagName(s)[0], j = d.createElement(s), dl = l != 'dataLayer' ? We are strongly committed to protecting your privacy.         E-mail Dan.     
 
 Company has co-headquarters in Chesterbrook, PA and Zug, Switzerland. Execute complex, global carve-out across 90+ countries to form a new stand-up company. You may unsubscribe at any time.     ​
 We are strongly committed to protecting your privacy. You may unsubscribe at any time. Platinum Equity Completes $2.1 Billion Acquisition of LifeScan from Johnson & Johnson, E-mail Platinum Equity Business Development.     
 The firm is currently investing from Platinum Equity Capital Partners IV, a $6.5 billion global buyout fund.     ​
 
 
 '&l=' + l : ''; j.async = true; j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f); })(window, document, 'script', 'dataLayer', 'GTM-TQKGM74'); Mark Barnhill
 The OneTouch portfolio includes personal blood glucose meters, testing strips, lancets, point of care testing systems and integrated digital solutions. 
     
         
     
 “We believe strongly in the company’s core mission and are committed to helping LifeScan continue improving the quality of life for people living with diabetes.”, Mark Barnhill
 Acquired LifeScan, Inc. from Johnson & Johnson in October 2018. ​
 All Rights Reserved. NEW BRUNSWICK, N.J. (June 12, 2018) – Johnson & Johnson (NYSE: JNJ) today announced that it has accepted the binding offer from Platinum Equity, previously announced on March 16, 2018, to acquire its LifeScan business for approximately $2.1 billion.     
         E-mail Mark, Dan Whelan
 Johnson & Johnson schließt Veräußerung von LifeScan an Platinum Equity ab New Brunswick, New Jersey (ots/PRNewswire) - LifeScan Inc. ist weltweit führend …         
 LifeScan is a leader in blood glucose monitoring products with 2017 net revenue of approximately $1.5 billion. If the offer is accepted, the transaction would be expected to close by the end of 2018, subject to the satisfaction of customary closing conditions. Platinum Equity specializes in closing complex acquisitions across a diverse range of industries. “We have worked closely with Johnson & Johnson to craft a divestiture solution for LifeScan that would create a global standalone business and set the stage for continued investment in growth and innovation.”.     
 
 Increase online, retail, and Point of Care presence in select markets. Global pharmaceutical company Johnson & Johnson has accepted investment firm Plantinum Equity’s offer to acquire LifeScan, its blood glucose monitoring business, for approximately $2.1bn. All Rights Reserved. “LifeScan’s OneTouch® blood glucose monitoring products play an important role in the lives of millions of patients living with diabetes, and following a thorough review of all strategic options, we feel confident that the business would have a promising future with Platinum Equity,” said Ashley McEvoy, Company Group Chairman, Consumer Medical Devices, Johnson & Johnson.     
 ​
 We are strongly committed to protecting your privacy. LOS ANGELES (March 16, 2018) – Platinum Equity announced today that it has submitted a binding offer to acquire LifeScan, Inc. from Johnson & Johnson (NYSE: JNJ) in a transaction valued at approximately $2.1 billion. “LifeScan has been a leader in diabetes care for more than 30 years and has consistently developed and brought to market industry leading products,” said Platinum Equity Partner Jacob Kotzubei. Our Newsletter is subject to our Privacy Notice. You have successfully subscribed to our list. LifeScan is a leader in blood glucose monitoring products with 2017 net revenue of approximately $1.5 billion.         
 By clicking 'Send' you agree to receive communications from us. LifeScan, Inc. is a world leader in blood glucose monitoring and maker of the OneTouch® brand of products. 
 
 Our Newsletter is subject to our Privacy Notice.     ​
     
         
 NEW BRUNSWICK, N.J., March 16, 2018 – Johnson & Johnson (NYSE: JNJ) today announced that it has received a binding offer from Platinum Equity, a leading private investment firm, to acquire its LifeScan business for approximately $2.1 billion, subject to customary adjustments. The company markets blood glucose monitoring systems for home and hospital use under the global brand OneTouch.  
 Platinum Equity specializes in mergers, acquisitions and operations – a trademarked strategy it calls M&A&O. 
 By clicking 'Send' you agree to receive communications from us. By submitting your contact information, you acknowledge that you have read our Privacy Notice and that you consent to our processing of data in accordance with our Privacy Notice. You have successfully subscribed to our list.     
 '&l=' + l : ''; j.async = true; j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f); })(window, document, 'script', 'dataLayer', 'GTM-TQKGM74'); Healthcare • Corporate Divestiture • Acquired in October 2018, A provider of blood glucose monitoring products and solutions for the treatment of diabetes, Platinum Equity Business Development
 
         E-mail Mark, Dan Whelan
 
     ​
     
 You may unsubscribe at any time. Our deep pool of capital enables us to consider a wide range of deals; our M&A teams mitigate transaction and transition risks to the benefit of sellers, their employees, their customers, and their suppliers; and our operational expertise enables us to see opportunity where others may not. Signing up for our Newsletter is subject to our Privacy Notice. ® 2020 Platinum Equity Advisors, LLC. LifeScan is a leading provider of blood glucose monitoring products and solutions for the treatment of diabetes. We are committed to putting our financial resources and global operating expertise to work in support of the company’s core mission to improve the quality of life for people living with diabetes.”. There was a problem submitting your request. By submitting your contact information, you acknowledge that you have read our Privacy Notice and that you consent to our processing of data in accordance with our Privacy Notice.     
 You may unsubscribe at any time.             (function (w, d, s, l, i) { w[l] = w[l] || []; w[l].push({ 'gtm.start': new Date().getTime(), event: 'gtm.js' }); var f = d.getElementsByTagName(s)[0], j = d.createElement(s), dl = l != 'dataLayer' ?     
 +1 310.228.9514
 ​
 You have successfully subscribed to our list.     ​
 +1 310.712.1850.         
 All Rights Reserved.     ​
 Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc. ";s:7:"keyword";s:24:"platinum equity lifescan";s:5:"links";s:837:"<a href="http://newdestinychurchpc.com/blog/article.php?tag=government-advisor-salary-6bb478">Government Advisor Salary</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=kyle-edmund-wife-6bb478">Kyle Edmund Wife</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=gemma-jones-net-worth-6bb478">Gemma Jones Net Worth</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=shepparton-newspaper-classifieds-6bb478">Shepparton Newspaper Classifieds</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=LG-Phoenix-3-6bb478">LG Phoenix 3</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=non-eu-players-premier-league-6bb478">Non Eu Players Premier League</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=abbott-ensure-coupons-6bb478">Abbott Ensure Coupons</a>,
";s:7:"expired";i:-1;}